Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who wrote (338)	1/30/2000 11:04:00 AM
From: KewlHand	Read Replies (2) of 427

There is plenty of life left in the CLPA short squeeze yet. I suspect the smaller players have taken their beating and bowed out, and the bigger players have foolishly reached deeper into their pockets. It is my belief that the coming week or two will go down as a landmark in shorting history, when the larger players get vapourised upon the imminent FDA approval. Currently short position is 'estimated' since the short count dates from the 15th Jan to be about 5mm with an effective trading float of about 10mm (RB's hold 5mm long term). Does anyone have a 'model' for estimating how far that can push a price if they are all forced to cover say within three days of approval? I have had many discussions with people on this, but it all seems to be finger in the wind estimates, ranging from 100% to 500% increase. There MUST be a really good spreadsheet for this somewhere! Any input appreciated. regards kh

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next